Indication
Severe Infection
2 clinical trials
3 products
Clinical trial
Clinical Study of Individualized Vancomycin Dosing Based on Population Pharmacokinetic Model for Severe InfectionsStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Empirical VancomycinClinical trial
Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICUStatus: Active (not recruiting), Estimated PCD: 2018-10-22
Product
Drug Monitoring